National Health Investors Inc (NHI)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at National Health Investors Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 76.70 $ — 37% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 10.8% failed
- More than 10% revenue growth is expected for the coming year 5.7% failed
- Share count grows by less than 3% a year 1.7% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 71.1% passed
- Gross margin at 40% or higher and without meaningful erosion 36.7% failed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 4.1 x EBITDA failed
- Operating cash flow covers the profits of the last three years 217 m passed
- Return on capital at 15% or higher, or up versus two years ago 7.3% failed
- Insiders hold at least 10% or are net buyers 2.4% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 8.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 8
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 14.55 | 14.55 – 14.55 | 440 | 396.7% | 1 |
| 12/31/2027 | 3.31 | 3.03 – 3.64 | 461 | -77.3% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 1.26 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.95 | 28.90 | 86 | 7.90 | 50.40 | 58 | 52 |
| 2025: Q1 | 0.74 | 4.50 | 89 | 9.50 | 38.30 | 47 | 45 |
| 2025: Q2 | 0.79 | -2.40 | 91 | 6.70 | 40.80 | 61 | 59 |
| 2025: Q3 | 0.69 | 6.40 | 90 | 8.30 | 36.60 | 63 | 58 |
| 2025: Q4 | 0.81 | -14.80 | 107 | 24.20 | 35.80 | 69 | 59 |
| 2026: Q1 | 0.83 | 10.90 | 116 | 29.70 | 34.60 | 53 | 51 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 249 | 178 | 152 | 3.87 | 177 | 1,210 | 2,404 |
| 2017 | 279 | 198 | 159 | 3.87 | 197 | 1,322 | 2,546 |
| 2018 | 295 | 209 | 154 | 3.67 | 208 | 1,390 | 2,751 |
| 2019 | 318 | 220 | 160 | 3.67 | 241 | 1,498 | 3,042 |
| 2020 | 333 | 225 | 185 | 4.14 | 232 | 1,523 | 3,120 |
| 2021 | 299 | 185 | 112 | 2.44 | 211 | 1,517 | 2,839 |
| 2022 | 278 | 133 | 66 | 1.48 | 185 | 1,290 | 2,507 |
| 2023 | 320 | 179 | 136 | 3.13 | 184 | 1,254 | 2,488 |
| 2024 | 335 | 184 | 138 | 3.13 | 208 | 1,366 | 2,614 |
| 2025 | 379 | 195 | 142 | 3.02 | 240 | 1,522 | 2,797 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
| Employees | 32 |
|---|---|
| Headquarters | Murfreesboro, TN |
| Address | 222 Robert Rose Drive, 37129-6346 Murfreesboro, United States |
| Phone | 615 890 9100 |
| Website | nhireit.com |
| IPO Date | 9. Oct 1991 |
| ISIN | US63633D1046 |
Management
| Name | Title | Birth Year |
|---|---|---|
| D. Eric Mendelsohn | President, CEO & Director | 1962 |
| Kevin Carlton Pascoe | Executive VP of Investments & Chief Investment Officer | 1981 |
| David Louis Travis | Senior VP & Chief Accounting Officer | 1975 |
| Kristin Sallee Gaines | Senior VP & Chief Transaction Officer | 1972 |
| Todd M. Siefert | Chief Financial Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Maingot Christian Ken | Chief Operating Officer | Other | 2,370 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.